Yahoo
OTC Markets OTCPK - Delayed Quote USD

Brain Scientific Inc. (BRSF)

0.0006 0.0000 (0.00%)
At close: October 30 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for BRSF
  • Previous Close 0.0006
  • Open 0.0001
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0006
  • Volume 108
  • Avg. Volume 0
  • Market Cap (intraday) 745
  • Beta (5Y Monthly) 1.64
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Brain Scientific Inc., a medtech company, provides neurology and motion products in the United States and internationally. It offers NeuroCap, a disposable soft layered cap with an integrated electrode circuit that is designed to address existing problems of conventional electroencephalography (EEG) systems; NeuroEEG amplifier and desktop software used to store and analyze data captured from the NeuroCap; and piezoelectric motors. The company is also developing NeuroHub, which allow users to access patient and clinical data to evaluate patient conditions remotely. Its NeuroCap and NeuroEEG products can be used for recording EEG in neurology clinics, urban and rural ED's, ICU's, urgent care clinics, nursing homes and assisted living facilities, sports facilities, remote clinical research studies, and other settings. Brain Scientific Inc. was founded in 2013 and is headquartered in Sarasota, Florida.

11

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BRSF
500.00%
S&P 500 (^GSPC)
10.73%

1-Year Return

BRSF
500.00%
S&P 500 (^GSPC)
11.11%

3-Year Return

BRSF
99.92%
S&P 500 (^GSPC)
81.91%

5-Year Return

BRSF
100.00%
S&P 500 (^GSPC)
64.59%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -47.81%

  • Return on Equity (ttm)

    -681.55%

  • Revenue (ttm)

    214.56k

  • Net Income Avi to Common (ttm)

    -12.34M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    747.71k

  • Total Debt/Equity (mrq)

    66.33%

  • Levered Free Cash Flow (ttm)

    -208.39k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: